Balance Training in Diabetic Neuropathy

Diabetic Neuropathy With Neurologic Complication Clinical Trial

Official title:

Efficacy of Balance Training in Comparison to General Exercises Alone in Diabetic Neuropathy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04232995
• Other study ID #: RTazeem
• Status: Completed
• Phase: N/A
• Start date: March 12, 2019
• Est. completion date: November 1, 2020

Study information

• Verified date: August 2021
• Source: Dow University of Health Sciences
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the efficacy of balance training in Diabetic Neuropathy. Control group will receive general exercises while Eperimental/ Interventional group will receive Balance exercises along with general exercises.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: November 1, 2020
• Est. primary completion date: September 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 60 Years

Eligibility

Inclusion Criteria:

• Age group: 30-60 years

• Diabetes type II patients diagnosed with peripheral neuropathy by medical doctor for at least 5 years

• Neuropathy present (on the basis of Michigan Neuropathy Screening Instrument

• Have balance impairment ( evaluation on Berg Balance Scale)

Exclusion Criteria:

• Neuropathy due to other medical conditions like Vitamin deficiency, Hypothyroidism, Auto-immune/ demyelinating diseases

• Foot ulcers

• Lower limb amputee

• Vestibular diseases

• Retinopathy

• Cardiac problems

• Hemiplegia/ Stroke

Related Conditions & MeSH terms

• Diabetic Neuropathies
• Diabetic Neuropathy With Neurologic Complication
• Peripheral Nervous System Diseases

Intervention

Other:
• Balance Training
Balance enhancing exercises
• General Exercises
General Exercises

Locations

Country	Name	City	State
Pakistan	Institute of Physical Medicine and Rehabilitation, Dow University of Health Sciences	Karachi	Sindh

Sponsors (1)

Lead Sponsor	Collaborator
Dow University of Health Sciences

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Berg Balance Scale	The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks. Katherine Berg developed this test to assess the level of function and balance in various patient populations. Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)	Baseline (Pre treatment)
Primary	Berg Balance Scale	The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks. Katherine Berg developed this test to assess the level of function and balance in various patient populations. Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)	At 4th week of treatment
Primary	Berg Balance Scale	The Berg Balance Scale (BBS) is a 56-point scale that evaluates 14 tasks. Katherine Berg developed this test to assess the level of function and balance in various patient populations. Minimum score is 0 (means severe balance deficit) and Maximum score is 56 (means No balance deficit)	At 8th week of treatment (Post treatment )